Evidence map›Paper›PMID 42141159›Full record

ArticleNpj viruses2026

Hemagglutinin E190D substitution in clade 2.3.4.4b A(H5N1) influenza virus reduces receptor binding and viral fitness.

Xiangjie Sun, Claudia Lisboa, Paul J Carney, Jessie C Chang, Brandon L Bradley-Ferrell, Xiao-Yu Zheng, Jessica A Belser, Nicole Brock, Troy J Kieran, Hui Zeng and 4 more

Abstract read
In one paragraph

Article in Npj viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xiangjie SunCenters for Disease Control and Prevention, Atlanta, GA, USA. jgz1@cdc.gov.
Claudia LisboaCenters for Disease Control and Prevention, Atlanta, GA, USA.
Paul J CarneyCenters for Disease Control and Prevention, Atlanta, GA, USA.
Jessie C ChangCenters for Disease Control and Prevention, Atlanta, GA, USA.
Brandon L Bradley-FerrellCenters for Disease Control and Prevention, Atlanta, GA, USA.
Xiao-Yu ZhengCenters for Disease Control and Prevention, Atlanta, GA, USA.
Jessica A BelserCenters for Disease Control and Prevention, Atlanta, GA, USA.
Nicole BrockCenters for Disease Control and Prevention, Atlanta, GA, USA.
Troy J KieranCenters for Disease Control and Prevention, Atlanta, GA, USA.
Hui ZengCenters for Disease Control and Prevention, Atlanta, GA, USA.
Joanna A Pulit-PenalozaCenters for Disease Control and Prevention, Atlanta, GA, USA.
Rebecca J KondorCenters for Disease Control and Prevention, Atlanta, GA, USA.
James StevensCenters for Disease Control and Prevention, Atlanta, GA, USA.
Taronna R MainesCenters for Disease Control and Prevention, Atlanta, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The detection of a clade 2.3.4.4b influenza A(H5N1) virus bearing an HA-E190D substitution in an infected human raises concern about mammalian adaptation. We evaluated the impact of the naturally occurring HA-E190D substitution in the A/British Columbia/PHL-2032/2024 (BC/24) virus on receptor binding specificity and viral fitness in vitro and in vivo. Recombinant BC/24 HA-E190D protein retained α2,3-linked sialic acid binding specificity but with reduced binding affinity. In cell culture, BC/24 viruses dominated by HA-190D were frequently outcompeted by the minor HA-190E variant in the inoculum, whereas BC/24 HA-190E viruses maintained dominance in the presence of residual HA-190D in the inoculum. In ferrets, BC/24 HA-190D viruses were similarly outcompeted by HA-190E; in one out of six ferrets where HA-190D dominance persisted, the virus was attenuated and failed to spread systemically. In contrast, BC/24 HA-190E viruses maintained dominance and disseminated systemically. These results indicate that the BC/24 variant bearing HA-E190D substitution did not acquire human-like receptor binding specificity and was less fit in mammalian hosts, making it unlikely to enhance public health risk without additional compensatory mutations.

Identifiers

PMID42141159
PMCPMC13434642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.